<DOC>
	<DOC>NCT03009487</DOC>
	<brief_summary>A multi-center, randomized, double-blind, phase III clinical trial to evaluate the efficacy and safety of Olmesartan/Amlodipine/Rosuvastatin combination treatment in patients with concomitant hypertension and hyperlipidemia</brief_summary>
	<brief_title>A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and Hyperlipidemia</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Olmesartan</mesh_term>
	<mesh_term>Olmesartan Medoxomil</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Amlodipine Besylate, Olmesartan Medoxomil Drug Combination</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Age 20 to 80 years patients with hypertension and hyperlipidemias orthostatic hypotension History of ventricular tachycardia, atrial fibrillation uncontrolled diabetes mellitus</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>